Dr. Bayard Powell, MD
Claim this profileWake Forest University Health Sciences
Studies Leukemia
Studies Myeloid Leukemia
8 reported clinical trials
29 drugs studied
Area of expertise
1Leukemia
BCR-ABL1 positive
T315I negative
BCOR positive
2Myeloid Leukemia
BCR-ABL1 positive
T315I negative
BCOR positive
Affiliated Hospitals
Clinical Trials Bayard Powell, MD is currently running
Blinatumomab + Chemotherapy
for Leukemia
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab. Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ability of cancer cells to grow and spread. The information gained from this study may help researchers determine if combination therapy with steroids, TKIs, and blinatumomab work better than the standard of care.
Recruiting2 awards Phase 310 criteria
Pomalidomide + Chemotherapy
for Acute Myeloid Leukemia
This trial is testing if adding pomalidomide to standard chemotherapy can improve treatment for patients with a specific type of newly diagnosed leukemia. Pomalidomide works by cutting off the blood supply to cancer, boosting the immune system, and killing cancer cells. The chemotherapy drugs attack cancer cells in multiple ways. Pomalidomide is related to thalidomide and has shown remarkable activity in patients who did not respond to other treatments.
Recruiting1 award Phase 23 criteria
More about Bayard Powell, MD
Clinical Trial Related3 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Bayard Powell, MD has experience with
- Inotuzumab Ozogamicin
- Methotrexate
- Vincristine Sulfate
- Cytarabine
- Dexamethasone
- Cyclophosphamide
Breakdown of trials Bayard Powell, MD has run
Leukemia
Myeloid Leukemia
Chronic Myeloid Leukemia
Lymphoblastic Leukemia-Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Bayard Powell, MD specialize in?
Bayard Powell, MD focuses on Leukemia and Myeloid Leukemia. In particular, much of their work with Leukemia has involved BCR-ABL1 positive patients, or patients who are T315I negative.
Is Bayard Powell, MD currently recruiting for clinical trials?
Yes, Bayard Powell, MD is currently recruiting for 4 clinical trials in Winston-Salem North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Bayard Powell, MD has studied deeply?
Yes, Bayard Powell, MD has studied treatments such as Inotuzumab Ozogamicin, Methotrexate, Vincristine Sulfate.
What is the best way to schedule an appointment with Bayard Powell, MD?
Apply for one of the trials that Bayard Powell, MD is conducting.
What is the office address of Bayard Powell, MD?
The office of Bayard Powell, MD is located at: Wake Forest University Health Sciences, Winston-Salem, North Carolina 27157 United States. This is the address for their practice at the Wake Forest University Health Sciences.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.